We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+14.21%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$987M
AUM Growth
+$120M
(+14%)
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
6.44%
Top 10 Holdings %
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.71M |
| 2 |
DexCom
DXCM
|
+$6.59M |
| 3 |
X
US Steel
X
|
+$6.1M |
| 4 |
CMBT
CMB.TECH NV
CMBT
|
+$5.09M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$4.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GOOS
Canada Goose Holdings
GOOS
|
+$21.9M |
| 2 |
Constellation Brands
STZ
|
+$9.52M |
| 3 |
Lumen
LUMN
|
+$7.13M |
| 4 |
Weyerhaeuser
WY
|
+$6.3M |
| 5 |
FedEx
FDX
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.75% |
| 2 | Technology | 15.19% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Industrials | 12.06% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Inogen
INGN
$164M
| $321K | 0.03% |
3,368
-5,510
| -62% | -$687K |
|
|
CLSD
952
DELISTED
Clearside Biomedical
CLSD
| $320K | 0.03% |
15,458
+7,457
| +93% | +$148K |
|
953
Outfront Media
OUT
$5.49B
| $320K | 0.03% |
13,902
-30,207
| -68% | -$633K |
|
954
Visa
V
$677B
| $320K | 0.03% |
2,050
-3,001
| -59% | -$432K |
|
955
Under Armour
UAA
$2.6B
| $319K | 0.03% |
+15,092
| New | +$316K |
|
|
CARB
956
DELISTED
Carbonite Inc
CARB
| $316K | 0.03% |
+12,752
| New | +$328K |
|
957
Franklin Electric
FELE
$4.84B
| $315K | 0.03% |
+6,157
| New | +$303K |
|
|
NRT
958
North European Oil Royalty Trust
NRT
$81M
| $315K | 0.03% |
45,777
| – | – |
|
959
Teleflex
TFX
$5.98B
| $315K | 0.03% |
+1,042
| New | +$290K |
|
|
AMPE
960
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $314K | 0.03% |
1,865
-354
| -16% | -$60.6K |
|
|
WAAS
961
DELISTED
AquaVenture Holdings Limited
WAAS
| $314K | 0.03% |
16,218
+997
| +7% | +$20.6K |
|
|
CBB
962
DELISTED
Cincinnati Bell Inc.
CBB
| $314K | 0.03% |
+32,956
| New | +$298K |
|
963
UFP Industries
UFPI
$5.19B
| $313K | 0.03% |
10,477
-5,672
| -35% | -$170K |
|
|
RPAI
964
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $313K | 0.03% |
+25,637
| New | +$312K |
|
965
Shenandoah Telecom
SHEN
$746M
| $312K | 0.03% |
7,029
-8,076
| -53% | -$379K |
|
966
Voya Financial
VOYA
$9.19B
| $312K | 0.03% |
6,248
+961
| +18% | +$45.6K |
|
967
Vishay Precision Group
VPG
$914M
| $312K | 0.03% |
9,108
-1,792
| -16% | -$59.9K |
|
968
Tennant Co
TNC
$1.26B
| $311K | 0.03% |
5,014
-3,051
| -38% | -$183K |
|
|
ARQL
969
DELISTED
Arqule Inc
ARQL
| $311K | 0.03% |
64,953
+25,953
| +67% | +$100K |
|
|
ORIT
970
DELISTED
Oritani Financial Corp. New
ORIT
| $311K | 0.03% |
+18,686
| New | +$314K |
|
971
AerCap
AER
$23.8B
| $310K | 0.03% |
+6,655
| New | +$300K |
|
972
IDEX
IEX
$17.3B
| $310K | 0.03% |
+2,041
| New | +$289K |
|
973
Sarepta Therapeutics
SRPT
$1.77B
| $310K | 0.03% |
+2,597
| New | +$334K |
|
|
CDMO
974
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $310K | 0.03% |
+72,967
| New | +$298K |
|
|
CSFL
975
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $310K | 0.03% |
13,021
+1,799
| +16% | +$44.5K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2019 Portfolio in Review
As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.
- GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
- GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
- GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
- GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
- GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
- GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
- GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.
Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.